Bridge Pharmaceuticals
Latest round
- Series C
Last raised
- Feb 2007
Total raised
- $61M
Investors
- 5
About Bridge Pharmaceuticals
Bridge Pharmaceuticals is the leading preclinical contract research organization in US. It include general and specialized toxicology, developmental and reproductive toxicology (DART), safety pharmacology, carcinogenicity testing and vaccine development in support of IND and NDA submissions.
Who invested in Bridge Pharmaceuticals
5 investors across 3 rounds
See all investors in Bridge Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bridge Pharmaceuticals
Who invested in Bridge Pharmaceuticals?
Bridge Pharmaceuticals has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bridge Pharmaceuticals raised?
Bridge Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Bridge Pharmaceuticals last raise money?
Bridge Pharmaceuticals's most recent round on record is a Series C, in Feb 2007.
What does Bridge Pharmaceuticals do?
Bridge Pharmaceuticals is the leading preclinical contract research organization in US.
Where is Bridge Pharmaceuticals headquartered?
Bridge Pharmaceuticals is headquartered in US.
Which VCs invest in companies like Bridge Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Bridge Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Bridge Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.